Kalamazoo Community Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2016
NCT02726035
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now